Other
OPTIMIZED
OPTIMIZED is an intervention with 3 clinical trials. Historical success rate of 33.3%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
33.3%
Based on 1 completed trials
Completion Rate
33%(1/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(67%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(2)
Detailed Status
Terminated2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
33.3%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed133%
terminated267%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Patient-ventilator Synchronisation Study for Intensive Care Unit Patients
NCT03787173
terminatednot_applicable
Impact of Early Goal-directed Fluid Therapy in Septic Patients Undergoing Emergency Surgery
NCT01654003
terminatednot_applicable
Impact of Early Goal-directed Fluid Therapy in Hypovolemic Patients Undergoing Emergency Surgery
NCT01653977
Clinical Trials (3)
Showing 3 of 3 trials
NCT03787173Not Applicable
Patient-ventilator Synchronisation Study for Intensive Care Unit Patients
NCT01654003Not Applicable
Impact of Early Goal-directed Fluid Therapy in Septic Patients Undergoing Emergency Surgery
NCT01653977Not Applicable
Impact of Early Goal-directed Fluid Therapy in Hypovolemic Patients Undergoing Emergency Surgery
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3